Association of triglyceride-glucose and triglyceride-glucose body mass indexes with risk and prognosis of lung cancer: a systematic review and meta-analysis.
- 1Department of Cardiothoracic Surgery, Guizhou Provincial Staff Hospital, Guiyang, China.
- 2Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China.
Abstract
The relationship of triglyceride-glucose (TyG) index and triglyceride-glucose body mass index (TyG-BMI) with the risk of lung cancer and survival of patients with lung cancer remains unclear. This meta-analysis aimed to clarify the association of TyG index and TyG-BMI with the risk of lung cancer and survival of lung cancer patients. Several databases were searched up to July 2, 2026. Odds ratios (ORs) and hazard ratios (HRs) were combined to assess the association of TyG index and TyG-BMI with risk and prognosis of lung cancer, respectively. Subgroup analyses based on study design, tumor type, treatment and combination of diabetes mellitus (DM) were performed. Thirteen studies were included. Pooled analyses demonstrated that higher TyG index [OR =2.42, 95% confidence interval (CI): 1.54-3.81, P<0.001] and TyG-BMI (OR =1.01, 95% CI: 1.01-1.02, P<0.001) were significantly related to increased risk of lung cancer. Subgroup analyses based on the study design and tumor type manifested similar results. However, subgroup analysis based on the combination of DM indicated that the significant association of TyG index and TyG-BMI with lung cancer risk was only observed among the population without DM. Besides, a higher TyG index was associated with poorer overall survival (OS) (HR =2.24, 95% CI: 1.49-3.37, P<0.001) and progression-free survival (PFS) (HR =3.09, 95% CI: 1.78-5.37, P<0.001). TyG-BMI was also related to OS (HR =1.86, 95% CI: 1.36-2.56, P<0.001) and PFS (HR =2.34, 95% CI: 1.20-4.56, P=0.01). Subgroup analyses stratified by treatment and tumor type indicated consistent findings, but association of TyG-BMI with OS was only observed in non-diabetic patients. Elevated TyG index and TyG-BMI are significantly associated with increased risk of lung cancer and poorer survival outcomes, particularly among non-diabetic individuals.
Related
- Association of the triglyceride-glucose index with prostate cancer risk and prognosis: a systematic review and meta-analysis
- Association of the triglyceride-glucose index and triglyceride-glucose-body mass index with postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass grafting: a retrospective cohort study
- Association of triglyceride-glucose and its related indices with circadian syndrome : Evidence from a prospective cohort study
- Association between triglyceride glucose–relative fat mass index and obstructive sleep apnea risk : A cross-sectional study from NHANES
- Association between triglyceride-glucose index and total trabecular bone score in US adults : A cross-sectional study
BibTeX
@article{jian2026association,
title = {{Association of triglyceride-glucose and triglyceride-glucose body mass indexes with risk and prognosis of lung cancer: a systematic review and meta-analysis.}},
author = {Zhongli Jian and Song Chen and Lirao Tang and Yan Wang and Jiaxin Li},
journal = {Journal of thoracic disease},
year = {2026},
month = sep,
doi = {10.21037/jtd-2026-2109},
url = {https://europepmc.org/article/MED/42996990},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Association of triglyceride-glucose and triglyceride-glucose body mass indexes with risk and prognosis of lung cancer: a systematic review and meta-analysis.
AU - Zhongli Jian
AU - Song Chen
AU - Lirao Tang
AU - Yan Wang
AU - Jiaxin Li
PY - 2026
DA - 2026/09/30
JO - Journal of thoracic disease
DO - 10.21037/jtd-2026-2109
UR - https://europepmc.org/article/MED/42996990
AB - The relationship of triglyceride-glucose (TyG) index and triglyceride-glucose body mass index (TyG-BMI) with the risk of lung cancer and survival of patients with lung cancer remains unclear. This meta-analysis aimed to clarify the association of TyG index and TyG-BMI with the risk of lung cancer and survival of lung cancer patients. Several databases were searched up to July 2, 2026. Odds ratios (ORs) and hazard ratios (HRs) were combined to assess the association of TyG index and TyG-BMI with risk and prognosis of lung cancer, respectively. Subgroup analyses based on study design, tumor type, treatment and combination of diabetes mellitus (DM) were performed. Thirteen studies were included. Pooled analyses demonstrated that higher TyG index [OR =2.42, 95% confidence interval (CI): 1.54-3.81, P<0.001] and TyG-BMI (OR =1.01, 95% CI: 1.01-1.02, P<0.001) were significantly related to increased risk of lung cancer. Subgroup analyses based on the study design and tumor type manifested similar results. However, subgroup analysis based on the combination of DM indicated that the significant association of TyG index and TyG-BMI with lung cancer risk was only observed among the population without DM. Besides, a higher TyG index was associated with poorer overall survival (OS) (HR =2.24, 95% CI: 1.49-3.37, P<0.001) and progression-free survival (PFS) (HR =3.09, 95% CI: 1.78-5.37, P<0.001). TyG-BMI was also related to OS (HR =1.86, 95% CI: 1.36-2.56, P<0.001) and PFS (HR =2.34, 95% CI: 1.20-4.56, P=0.01). Subgroup analyses stratified by treatment and tumor type indicated consistent findings, but association of TyG-BMI with OS was only observed in non-diabetic patients. Elevated TyG index and TyG-BMI are significantly associated with increased risk of lung cancer and poorer survival outcomes, particularly among non-diabetic individuals.
SN - 2072-1439
SN - 2077-6624
ER -